Atlas Trials

Dual REctcal Angiogenesis or MEK Inhibition radioTHERAPY Trial

Clinical trial NCT01160926 · TERMINATED

Trial details

NCT number
NCT01160926
Sponsor
The Christie NHS Foundation Trust
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2010-07-01
Primary completion
2013-10-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.